Hani Gabra
Founder presso Papyrus Therapeutics, Inc.
Posizioni attive di Hani Gabra
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Imperial College London | Corporate Officer/Principal | - | - |
Papyrus Therapeutics, Inc.
 Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Chief Tech/Sci/R&D Officer | - | - |
| Founder | - | - |
Storia della carriera di Hani Gabra
Precedenti posizioni note di Hani Gabra
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BERGENBIO ASA | Chief Tech/Sci/R&D Officer | 01/09/2019 | - |
| Corporate Officer/Principal | 06/08/2021 | 01/05/2022 | |
| ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
| Norvegia | 2 |
| Stati Uniti | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| BERGENBIO ASA | Health Technology |
| Aziende private | 1 |
|---|---|
Papyrus Therapeutics, Inc.
Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Hani Gabra
- Esperienza
